Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University Health Network, Toronto
Assistance Publique Hopitaux De Marseille
H. Lee Moffitt Cancer Center and Research Institute
Duke University
National Cancer Centre, Singapore
Incyte Corporation
National Cancer Institute (NCI)